Are they profound wisdom? Or are they bull? If you thought they were profound, you might need your BS detector checked. Created from the website wisdomofchopra.com, this “wisdom” was generated by ...

CEO Arun Menawat highlighted the CAPTAIN trial results presented at the American Urological Association Meeting, describing them as establishing TULSA's statistical superiority over robotic radical ...

Arun Menawat, CEO of Profound Medical, talks about the company’s innovative TULSA-PRO technology. In a recent interview, Arun Menawat, CEO of Profound Medical, discussed the company’s innovative TULSA ...

ChatGPT recently crossed one billion weekly active users, and more than 60 percent of consumers now start product research with an AI assistant instead of a traditional search engine. Yet most ...

In what may well be the first-ever paper to evaluate susceptibility to pseudo-profound BS, Gordon Pennycook and colleagues have found that people who are more susceptible to BS score lower for verbal ...

Profound Medical has an innovative product, Tulsa Pro, for prostate cancer and BPH, but has struggled with limited revenue growth and unprofitability since FDA approval in 2019. Despite recent revenue ...

Profound Medical (NASDAQ: PROF) on Wednesday had increased  its December 19, 2025, private placement to allow participation by a long-term existing investor, with gross proceeds of up to $6.45M from ...

We've discovered 2 warning signs about Profound Medical. View them for free. If you want to know who really controls Profound Medical Corp. (TSE:PRN), then you'll have to look at the makeup of its ...

"You can't be happy while your heart's on the roam / You can't be happy until you bring it home." –The Brothers Four "The secret of your future is hidden in your daily routine." –Mike Murdock It is ...

PROF is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of PROF shares has decreased $0.14 since the market last closed. This is a 1.86% ...